TEM241129P67000
- 4.00
- +0.10+2.56%
Tempus AI Newsroom
Will Ambry Genetics Acquisition Drive Tempus AI's Prospects?
Trending Stocks Today | Quantum Surges 152.57%
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference
S&P 500 Futures Climb In Premarket Trading; Bath & Body Works, Rocket Lab USA Lead
Cathie Wood's ARK Buys Tempus AI Stock, Sells Exact Sciences
Artificial Intelligence (AI) Reshaping Healthcare Industry With Unimaginable Potential
Top Institutions Continue to Hold Strong Tech Positions in Q3 13F Filings
Ray Dalio's Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?
SoundHound AI Plunges Despite Reporting Record Quarterly Revenue
Express News | Red Sky Ventures LLC Reports Passive Stake of 10.9% in Tempus AI as of September 30, 2024 - SEC Filing
ARKK's Holdings Ranked by SA Quant Grades
Trending Stocks Today | BTC Digital Surges 419.84%
Express News | Piper Sandler Reiterates Neutral on Tempus AI, Raises Price Target to $70
Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR
Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers
Tempus Announces Publication Of Its Study, "Actionable Structural Variant Detection Via RNA-NGS And DNA-NGS In Patients With Advanced Non-small Cell Lung Cancer," In Jama Network Open
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Nvidia To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday
Tempus AI Price Target Raised to $65.00/Share From $45.00 by Stifel